Δ133p53 is an independent prognostic marker in p53 mutant advanced serous ovarian cancer

被引:0
|
作者
G Hofstetter
A Berger
E Schuster
A Wolf
G Hager
I Vergote
I Cadron
J Sehouli
E I Braicu
S Mahner
P Speiser
C Marth
A G Zeimet
H Ulmer
R Zeillinger
N Concin
机构
[1] Innsbruck Medical University,Department of Gynecology and Obstetrics
[2] Molecular Oncology Group,Department of Obstetrics and Gynecology
[3] Medical University of Vienna,Division of Gynaecological Oncology, Department of Obstetrics and Gynaecology
[4] Universitaire Ziekenhuzen Leuven,Department of Gynecology
[5] Katholieke Universiteit Leuven,Department of Gynecology and Gynecologic Oncology
[6] European Competence Center for Ovarian Cancer,Department of Medical Statistics
[7] Campus Virchow Klinikum,undefined
[8] Charité – Universitätsmedizin Berlin,undefined
[9] University Medical Center Hamburg-Eppendorf,undefined
[10] Informatics,undefined
[11] and Health Economics,undefined
[12] Innsbruck Medical University,undefined
来源
British Journal of Cancer | 2011年 / 105卷
关键词
ovarian cancer; delta133p53; p53 isoforms; p53; p73;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:1593 / 1599
页数:6
相关论文
共 50 条
  • [21] Functional interplay between p53 and Δ133p53 in adaptive stress response
    Lu Gong
    Xiao Pan
    Gamze K. Abali
    John B. Little
    Zhi-Min Yuan
    Cell Death & Differentiation, 2020, 27 : 1618 - 1632
  • [22] p53 isoforms, Δ133p53 and p53β, regulate aging-associated T lymphocyte senescence.
    Mondal, Abdul Matin
    Horikawa, Lzumi
    Pine, Sharon R.
    Fujita, Kaori
    Vojtesek, Borivoj
    Bourdon, Jean-Christophe
    Vera, Elsa
    Lane, David P.
    Blasco, Maria A.
    Harris, Curtis C.
    CANCER RESEARCH, 2011, 71
  • [23] THE RATIO OF Δ133P53 EXPRESSION TO FULL-LENGTH P53 INDICATES IMPROVED OVERALL SURVIVAL IN HIGH-GRADE SEROUS OVARIAN CANCERS
    Bischof, K.
    Knappskog, S.
    Leirvaag, B.
    Gjertsen, B. T.
    Salvesen, H. B.
    Bjorge, L.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2015, 25 (09) : 1299 - 1299
  • [24] p53 Autoantibodies as Potential Detection and Prognostic Biomarkers in Serous Ovarian Cancer
    Anderson, Karen S.
    Wong, Jessica
    Vitonis, Allison
    Crum, Christopher P.
    Sluss, Patrick M.
    LaBaer, Joshua
    Cramer, Daniel
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2010, 19 (03) : 859 - 868
  • [25] Δ113p53/Δ133p53: survival and integrity
    Chen, Jun
    Peng, Jinrong
    ONCOTARGET, 2015, 6 (16) : 13850 - 13851
  • [26] Autophagic degradation of the inhibitory p53 isoform Δ133p53α as a regulatory mechanism for p53-mediated senescence
    Horikawa, Izumi
    Fujita, Kaori
    Jenkins, Lisa M. Miller
    Hiyoshi, Yukiharu
    Mondal, Abdul M.
    Vojtesek, Borivoj
    Lane, David P.
    Appella, Ettore
    Harris, Curtis C.
    NATURE COMMUNICATIONS, 2014, 5
  • [27] Δ160p53 is a novel N-terminal p53 isoform encoded by Δ133p53 transcript
    Marcel, Virginie
    Perrier, Stephane
    Aoubala, Mustapha
    Ageorges, Sylvain
    Groves, Michael J.
    Diot, Alexandra
    Fernandes, Kenneth
    Tauro, Sudhir
    Bourdon, Jean-Christophe
    FEBS LETTERS, 2010, 584 (21): : 4463 - 4468
  • [28] Conformational stability and dynamics of the cancer-associated isoform 133p53 are modulated by p53 peptides and p53-specific DNA
    Lei, Jiangtao
    Qi, Ruxi
    Tang, Yegen
    Wang, Wenning
    Wei, Guanghong
    Nussinov, Ruth
    Ma, Buyong
    FASEB JOURNAL, 2019, 33 (03): : 4225 - 4235
  • [29] Autophagic degradation of the inhibitory p53 isoform Δ133p53α as a regulatory mechanism for p53-mediated senescence
    Izumi Horikawa
    Kaori Fujita
    Lisa M Miller Jenkins
    Yukiharu Hiyoshi
    Abdul M. Mondal
    Borivoj Vojtesek
    David P. Lane
    Ettore Appella
    Curtis C. Harris
    Nature Communications, 5
  • [30] Mutant P53 Is a Key Determinant of Ovarian Cancer
    Mullany, Lisa K.
    Ren, Yi
    Marciano, David C.
    Wong, Kwong-Kwok
    King-Crane, Erin R.
    Katsonis, Panagiotis
    Liu, Zhilin
    Lichtarge, Olivier
    Richards, JoAnne S.
    ENDOCRINE REVIEWS, 2014, 35 (03)